Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12829031rdf:typepubmed:Citationlld:pubmed
pubmed-article:12829031lifeskim:mentionsumls-concept:C0037047lld:lifeskim
pubmed-article:12829031lifeskim:mentionsumls-concept:C0019156lld:lifeskim
pubmed-article:12829031lifeskim:mentionsumls-concept:C0439793lld:lifeskim
pubmed-article:12829031lifeskim:mentionsumls-concept:C1332710lld:lifeskim
pubmed-article:12829031lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:12829031lifeskim:mentionsumls-concept:C0242602lld:lifeskim
pubmed-article:12829031lifeskim:mentionsumls-concept:C0021149lld:lifeskim
pubmed-article:12829031lifeskim:mentionsumls-concept:C2347644lld:lifeskim
pubmed-article:12829031lifeskim:mentionsumls-concept:C1515895lld:lifeskim
pubmed-article:12829031pubmed:issue6lld:pubmed
pubmed-article:12829031pubmed:dateCreated2003-6-27lld:pubmed
pubmed-article:12829031pubmed:abstractTextT-cell depletion (TCD), primarily developed to prevent graft-vs-host disease (GVHD), might reduce early liver dysfunction after allogeneic hematopoietic stem cell transplantation. However, no comparative studies have been performed to investigate this. We analyzed the influence of selection for CD34(+) cells on the incidence and severity of hepatic veno-occlusive disease (VOD).lld:pubmed
pubmed-article:12829031pubmed:languageenglld:pubmed
pubmed-article:12829031pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12829031pubmed:citationSubsetIMlld:pubmed
pubmed-article:12829031pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12829031pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12829031pubmed:statusMEDLINElld:pubmed
pubmed-article:12829031pubmed:monthJunlld:pubmed
pubmed-article:12829031pubmed:issn0301-472Xlld:pubmed
pubmed-article:12829031pubmed:authorpubmed-author:SanzMiguel...lld:pubmed
pubmed-article:12829031pubmed:authorpubmed-author:SolanoCarlosClld:pubmed
pubmed-article:12829031pubmed:authorpubmed-author:SanzGuillermo...lld:pubmed
pubmed-article:12829031pubmed:authorpubmed-author:Urbano-Ispizu...lld:pubmed
pubmed-article:12829031pubmed:authorpubmed-author:BrunetSalutSlld:pubmed
pubmed-article:12829031pubmed:authorpubmed-author:CaballeroDolo...lld:pubmed
pubmed-article:12829031pubmed:authorpubmed-author:ArbonaCristin...lld:pubmed
pubmed-article:12829031pubmed:authorpubmed-author:EspigadoIldef...lld:pubmed
pubmed-article:12829031pubmed:authorpubmed-author:CampilhoFerna...lld:pubmed
pubmed-article:12829031pubmed:authorpubmed-author:PimentelPedro...lld:pubmed
pubmed-article:12829031pubmed:authorpubmed-author:FerráChristel...lld:pubmed
pubmed-article:12829031pubmed:authorpubmed-author:ZuazuJavierJlld:pubmed
pubmed-article:12829031pubmed:authorpubmed-author:SierraJordiJlld:pubmed
pubmed-article:12829031pubmed:authorpubmed-author:MateosMaría...lld:pubmed
pubmed-article:12829031pubmed:authorpubmed-author:MoscardóFeder...lld:pubmed
pubmed-article:12829031pubmed:authorpubmed-author:Pérez de...lld:pubmed
pubmed-article:12829031pubmed:authorpubmed-author:VallejoCarlos...lld:pubmed
pubmed-article:12829031pubmed:authorpubmed-author:Díez-MartínJo...lld:pubmed
pubmed-article:12829031pubmed:authorpubmed-author:MoraledaJosé...lld:pubmed
pubmed-article:12829031pubmed:authorpubmed-author:TalarnCarmenClld:pubmed
pubmed-article:12829031pubmed:issnTypePrintlld:pubmed
pubmed-article:12829031pubmed:volume31lld:pubmed
pubmed-article:12829031pubmed:ownerNLMlld:pubmed
pubmed-article:12829031pubmed:authorsCompleteYlld:pubmed
pubmed-article:12829031pubmed:pagination545-50lld:pubmed
pubmed-article:12829031pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12829031pubmed:meshHeadingpubmed-meshheading:12829031...lld:pubmed
pubmed-article:12829031pubmed:meshHeadingpubmed-meshheading:12829031...lld:pubmed
pubmed-article:12829031pubmed:meshHeadingpubmed-meshheading:12829031...lld:pubmed
pubmed-article:12829031pubmed:meshHeadingpubmed-meshheading:12829031...lld:pubmed
pubmed-article:12829031pubmed:meshHeadingpubmed-meshheading:12829031...lld:pubmed
pubmed-article:12829031pubmed:meshHeadingpubmed-meshheading:12829031...lld:pubmed
pubmed-article:12829031pubmed:meshHeadingpubmed-meshheading:12829031...lld:pubmed
pubmed-article:12829031pubmed:meshHeadingpubmed-meshheading:12829031...lld:pubmed
pubmed-article:12829031pubmed:meshHeadingpubmed-meshheading:12829031...lld:pubmed
pubmed-article:12829031pubmed:meshHeadingpubmed-meshheading:12829031...lld:pubmed
pubmed-article:12829031pubmed:meshHeadingpubmed-meshheading:12829031...lld:pubmed
pubmed-article:12829031pubmed:meshHeadingpubmed-meshheading:12829031...lld:pubmed
pubmed-article:12829031pubmed:meshHeadingpubmed-meshheading:12829031...lld:pubmed
pubmed-article:12829031pubmed:meshHeadingpubmed-meshheading:12829031...lld:pubmed
pubmed-article:12829031pubmed:meshHeadingpubmed-meshheading:12829031...lld:pubmed
pubmed-article:12829031pubmed:meshHeadingpubmed-meshheading:12829031...lld:pubmed
pubmed-article:12829031pubmed:year2003lld:pubmed
pubmed-article:12829031pubmed:articleTitlePositive selection for CD34+ reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation.lld:pubmed
pubmed-article:12829031pubmed:affiliationHematology Department, Hospital Universitario La Fe, Avda. Campanar 21, 46009 Valencia, Spain.lld:pubmed
pubmed-article:12829031pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12829031pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12829031pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:12829031pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12829031lld:pubmed